← Leaderboards
James J Galligan
University Of Colorado Denver
$3,543,008
Attributed
$3,543,008
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $826.6K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,543,008 · 3
By mechanism
R35$2,136,815 · 1
R01$1,328,736 · 1
F31$77,457 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Miguel Angel Lanaspa Garcia$4,460,819
- Cara C Wilson$18,310,415
- Mario Luis Santiago$9,294,870
- Paul S Maclean$8,462,583
- Margaret C Neville$2,586,798
Others in their field
Top investigators on “Modification”
- Peter C Adamson · National Childhood Cancer Foundation$114,476,581
- Randall J Bateman · Washington University$69,813,561
- Gregory H Reaman · National Childhood Cancer Foundation$62,692,489
- Bing Ren · Ludwig Institute For Cancer Research$58,236,047
- Paul S. Aisen · Cognition Therapeutics, Inc.$52,794,170
- Holly Janes · Fred Hutchinson Cancer Center$52,003,716
Research focus
ModificationDiabetes MellitusIn VivoResponseHomeostasisSensorSignal TransductionCrispr/Cas TechnologyReaderProteinsGlycolysisGlutathioneHistonesAntioxidantsMetabolicCell LineLactoylglutathione LyaseMetabolismOutputChromatinOxidation-ReductionPost-Translational Protein ProcessingRegulationSite
Grant awards (12)
Glyoxalase 1 and its Role in Metabolic Syndrome$465,631
R01 · FY2025 · DK · contact PI
Glyoxalase 1 and its Role in Metabolic Syndrome$449,263
R01 · FY2024 · DK · contact PI
Establishing Glyoxalase 2 as a Viable Target for the Treatment of Disease$377,363
R35 · FY2024 · GM · contact PI
Glyoxalase 1 and its Role in Metabolic Syndrome$413,842
R01 · FY2023 · DK · contact PI
Establishing Glyoxalase 2 as a Viable Target for the Treatment of Disease$377,363
R35 · FY2023 · GM · contact PI
Establishing Glyoxalase 2 as a Viable Target for the Treatment of Disease$377,363
R35 · FY2022 · GM · contact PI
Establishing Glyoxalase 2 as a Viable Target for the Treatment of Disease$377,363
R35 · FY2021 · GM · contact PI
Establishing Glyoxalase 2 as a Viable Target for the Treatment of Disease [Equipment Supplement]$250,000
R35 · FY2021 · GM · contact PI
Establishing Glyoxalase 2 as a Viable Target for the Treatment of Disease$377,363
R35 · FY2020 · GM · contact PI
Modification of PDI by 4-HNE and 4-ONE and its Role in Ethanol-Induced ER Stress$24,163
F31 · FY2011 · AA · contact PI
Modification of PDI by 4-HNE and 4-ONE and its Role in Ethanol-Induced ER Stress$26,749
F31 · FY2010 · AA · contact PI
Modification of PDI by 4-HNE and 4-ONE and its Role in Ethanol-Induced ER Stress$26,545
F31 · FY2009 · AA · contact PI